CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 124 filers reported holding CYTOKINETICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $101,812,943 | -18.0% | 1,879,161 | +6.2% | 0.04% | -18.2% |
| Q1 2024 | $124,099,257 | +1115.9% | 1,770,065 | +1347.9% | 0.04% | +1000.0% |
| Q4 2023 | $10,206,402 | +166.1% | 122,247 | -6.1% | 0.00% | +100.0% |
| Q3 2023 | $3,835,515 | -30.0% | 130,194 | -22.5% | 0.00% | 0.0% |
| Q2 2023 | $5,477,648 | -26.4% | 167,923 | -20.6% | 0.00% | -33.3% |
| Q1 2023 | $7,442,579 | -27.9% | 211,497 | -6.2% | 0.00% | -40.0% |
| Q4 2022 | $10,329,157 | -10.2% | 225,429 | -5.0% | 0.01% | -16.7% |
| Q3 2022 | $11,502,000 | -1.5% | 237,395 | -20.2% | 0.01% | +20.0% |
| Q2 2022 | $11,681,000 | +62.7% | 297,310 | +52.4% | 0.01% | +66.7% |
| Q1 2022 | $7,180,000 | -55.9% | 195,067 | -45.3% | 0.00% | -50.0% |
| Q4 2021 | $16,269,000 | +81.4% | 356,929 | +42.3% | 0.01% | +50.0% |
| Q3 2021 | $8,967,000 | -0.7% | 250,882 | -45.0% | 0.00% | 0.0% |
| Q2 2021 | $9,034,000 | +7.2% | 456,474 | +26.0% | 0.00% | 0.0% |
| Q1 2021 | $8,428,000 | +299.4% | 362,324 | +256.9% | 0.00% | +300.0% |
| Q4 2020 | $2,110,000 | -4.0% | 101,530 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,198,000 | +0.9% | 101,530 | +9.8% | 0.00% | 0.0% |
| Q2 2020 | $2,179,000 | +173.1% | 92,460 | +36.6% | 0.00% | 0.0% |
| Q1 2020 | $798,000 | +8.0% | 67,700 | -2.8% | 0.00% | – |
| Q4 2019 | $739,000 | -3.3% | 69,650 | +3.8% | 0.00% | – |
| Q3 2019 | $764,000 | -15.2% | 67,100 | -16.2% | 0.00% | -100.0% |
| Q2 2019 | $901,000 | +96.7% | 80,100 | +41.5% | 0.00% | – |
| Q1 2019 | $458,000 | +27.9% | 56,600 | 0.0% | 0.00% | – |
| Q4 2018 | $358,000 | -35.8% | 56,600 | 0.0% | 0.00% | – |
| Q3 2018 | $558,000 | +18.7% | 56,600 | 0.0% | 0.00% | – |
| Q2 2018 | $470,000 | +51.6% | 56,600 | +31.3% | 0.00% | – |
| Q1 2018 | $310,000 | -67.5% | 43,100 | -63.2% | 0.00% | -100.0% |
| Q4 2017 | $955,000 | -45.9% | 117,170 | -3.8% | 0.00% | 0.0% |
| Q3 2017 | $1,766,000 | +233.2% | 121,770 | +178.0% | 0.00% | – |
| Q2 2017 | $530,000 | +55.4% | 43,800 | +65.3% | 0.00% | – |
| Q1 2017 | $341,000 | +5.9% | 26,500 | 0.0% | 0.00% | – |
| Q4 2016 | $322,000 | +32.5% | 26,500 | 0.0% | 0.00% | – |
| Q3 2016 | $243,000 | -3.2% | 26,500 | 0.0% | 0.00% | – |
| Q2 2016 | $251,000 | +100.8% | 26,500 | +48.9% | 0.00% | – |
| Q1 2016 | $125,000 | -34.9% | 17,800 | -3.1% | 0.00% | – |
| Q4 2015 | $192,000 | +61.3% | 18,360 | +3.1% | 0.00% | – |
| Q3 2015 | $119,000 | -0.8% | 17,800 | 0.0% | 0.00% | – |
| Q2 2015 | $120,000 | +13.2% | 17,800 | +13.4% | 0.00% | – |
| Q1 2015 | $106,000 | +53.6% | 15,700 | +82.6% | 0.00% | – |
| Q4 2014 | $69,000 | +56.8% | 8,600 | -30.6% | 0.00% | – |
| Q3 2014 | $44,000 | -25.4% | 12,400 | 0.0% | 0.00% | – |
| Q2 2014 | $59,000 | -29.8% | 12,400 | +39.5% | 0.00% | – |
| Q1 2014 | $84,000 | -32.3% | 8,890 | -53.4% | 0.00% | – |
| Q4 2013 | $124,000 | -45.6% | 19,094 | -36.5% | 0.00% | – |
| Q3 2013 | $228,000 | – | 30,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 325,000 | $6,754,000 | 6.26% |
| RP Management, LLC | 875,656 | $18,196,000 | 5.58% |
| BVF INC/IL | 4,878,035 | $101,366,000 | 3.99% |
| Burrage Capital Management LLC | 246,036 | $5,113,000 | 3.90% |
| Integral Health Asset Management, LLC | 525,000 | $10,910,000 | 3.24% |
| Foresite Capital Management IV, LLC | 1,435,992 | $29,840,000 | 3.24% |
| Opaleye Management Inc. | 582,800 | $12,111,000 | 1.58% |
| Boxer Capital, LLC | 2,100,000 | $43,638,000 | 1.40% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3,226,567 | $67,048,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,461,000 | $51,140,000 | 1.01% |